SCHEMBL5045228

SCHEMBL5045228

N[C@@H](CC(=O)O)c1cnc2ccccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.50
ITGB3 P05106 3/20 0.49
ITGA2B P08514 1/20 0.49
RAB9A P51151 2/20 0.48
SMN1; SMN2 Q16637 3/20 0.46
KMT2A Q03164 2/20 0.46
TPH1 P17752 1/20 0.44
CFTR P13569 1/20 0.44
CYP1A2 P05177 1/20 0.44
KDR P35968 1/20 0.43
PDE4D Q08499 1/20 0.43
ITGAV P06756 2/20 0.43
ACP1 P24666 1/20 0.43
PDGFRB P09619 1/20 0.43
PDGFRA P16234 1/20 0.43
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7229467 1.00 MGAM (0.50) MGAMITGB3ITGA2BRAB9ASMN1; SMN2
SCHEMBL5045237 1.00 MGAM (0.50) MGAMITGB3ITGA2BRAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL6106793 0.99 MGAM (0.49) MGAMITGB3ITGA2BRAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL6106794 0.99 MGAM (0.49) MGAMITGB3ITGA2BRAB9ASMN1; SMN2
SCHEMBL5857685 0.85 MGAM (0.53) MGAMITGB3ITGA2BRAB9ASMN1; SMN2
SCHEMBL5041314 0.83 KDM4E (0.49) MGAMITGB3ITGA2BRAB9ASMN1; SMN2
SCHEMBL13344628 0.83 KDM4E (0.49) MGAMITGB3ITGA2BRAB9ASMN1; SMN2
SCHEMBL20157741 0.82 KDM4E (0.49) MGAMRAB9ASMN1; SMN2KMT2ACYP1A2
SCHEMBL29511481 0.82 KDM4E (0.49) MGAMRAB9ASMN1; SMN2KMT2ACYP1A2
Hydrochloric Acid SCHEMBL6506600 0.82 KDM4E (0.48) MGAMITGB3ITGA2BRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1988078-B1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders ORTHO MCNEIL PHARM INC (US) 2012-10-17 EP disclosed
EP-1988078-A1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders Ortho-McNeil Pharmaceutical, Inc. (US) 2008-11-05 EP disclosed
EP-0923555-B1 CARBOXAMIDE DERIVATIVES OF PYRROLIDINE, PIPERIDINE AND HEXAHYDROAZEPINE FOR THE TREATMENT OF THROMBOSIS DISORDERS ORTHO MCNEIL PHARM INC (US) 2005-06-15 EP disclosed
EP-1184374-A1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders ORTHO PHARMACEUTICAL CORPORATION (US) 2002-03-06 EP disclosed
US-6069254-A Carboxamide derivatives of piperidine for the treatment of thrombosis disorders ORTHO PHARMACEUTICAL CORP. (US) 2000-05-30 US disclosed
EP-0923555-A1 CARBOXAMIDE DERIVATIVES OF PYRROLIDINE, PIPERIDINE AND HEXAHYDROAZEPINE FOR THE TREATMENT OF THROMBOSIS DISORDERS ORTHO PHARMACEUTICAL CORPORATION (US) 1999-06-23 EP disclosed
WO-1997041102-A1 CARBOXAMIDE DERIVATIVES OF PYRROLIDINE, PIPERIDINE AND HEXAHYDROAZEPINE FOR THE TREATMENT OF THROMBOSIS DISORDERS ORTHO PHARMACEUTICAL CORPORATION (US) 1997-11-06 WO disclosed